Osteoarthritis as an aging-driven multi-tissue disorder - genomic instability, cellular senescence, and emerging gerotherapeutic strategies

Background. Osteoarthritis (OA) is the most common musculoskeletal disorder and a major cause of disability in older adults. Once considered primarily a consequence of mechanical wear, OA is now recognized as an aging-driven, multi-tissue degenerative disease. Processes such as genomic instability, mitochondrial dysfunction, and cellular senescence play central roles in disease initiation and progression. Objective and methods. This review synthesizes mechanistic evidence linking biological aging to OA pathogenesis and evaluates emerging senescence-targeted therapies. A PRISMA-informed narrative search of PubMed, Embase, Cochrane Central, and Google Scholar identified 86 relevant clinical and preclinical studies from 360 screened records. Results. Aging chondrocytes accumulate DNA damage, telomere shortening, and metabolic dysfunction, leading to persistent senescence and a pro-inflammatory SASP. Senescent cells across cartilage, synovium, subchondral bone, and adipose tissue interact via paracrine and extracellular vesicle signaling, driving chronic inflammation and matrix degradation. Preclinical data show that interventions targeting aging hallmarks – including senolytics, senomorphics, autophagy activation, NAD⁺ restoration, stem cell-based therapies, and lifestyle modification–can reduce senescence burden and slow structural decline, though human evidence remains limited. Conclusion. OA should be reframed as an aging-mediated systemic joint disorder rather than isolated cartilage failure. Therapies addressing upstream mechanisms of cellular aging offer realistic potential for disease modification, but successful translation will require age-adapted clinical strategies and biomarker-guided patient selection. Keywords: osteoarthritis, aging, genomic instability, chondrocyte senescence, SASP.

Authors

Publication Details

Journal
Clinical review for general practice
Published
2026-11-16
DOI
https://doi.org/10.47407/kr2026.7.9.00935
Primary Topic
Osteoarthritis Treatment and Mechanisms
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Osteoarthritis as an aging-driven multi-tissue disorder - genomic instability, cellular senescence, and emerging gerotherapeutic strategies

Khaled A Abdel-Sater
Clinical review for general practice
Osteoarthritis Treatment and Mechanisms
article

Osteoarthritis as an aging-driven multi-tissue disorder - genomic instability, cellular senescence, and emerging gerotherapeutic strategies

Khaled A Abdel-Sater
article en

Abstract

Background. Osteoarthritis (OA) is the most common musculoskeletal disorder and a major cause of disability in older adults. Once considered primarily a consequence of mechanical wear, OA is now recognized as an aging-driven, multi-tissue degenerative disease. Processes such as genomic instability, mitochondrial dysfunction, and cellular senescence play central roles in disease initiation and progression. Objective and methods. This review synthesizes mechanistic evidence linking biological aging to OA pathogenesis and evaluates emerging senescence-targeted therapies. A PRISMA-informed narrative search of PubMed, Embase, Cochrane Central, and Google Scholar identified 86 relevant clinical and preclinical studies from 360 screened records. Results. Aging chondrocytes accumulate DNA damage, telomere shortening, and metabolic dysfunction, leading to persistent senescence and a pro-inflammatory SASP. Senescent cells across cartilage, synovium, subchondral bone, and adipose tissue interact via paracrine and extracellular vesicle signaling, driving chronic inflammation and matrix degradation. Preclinical data show that interventions targeting aging hallmarks – including senolytics, senomorphics, autophagy activation, NAD⁺ restoration, stem cell-based therapies, and lifestyle modification–can reduce senescence burden and slow structural decline, though human evidence remains limited. Conclusion. OA should be reframed as an aging-mediated systemic joint disorder rather than isolated cartilage failure. Therapies addressing upstream mechanisms of cellular aging offer realistic potential for disease modification, but successful translation will require age-adapted clinical strategies and biomarker-guided patient selection. Keywords: osteoarthritis, aging, genomic instability, chondrocyte senescence, SASP.

Clinical review for general practiceVol. 7(9)
Good health and well-being
Osteoarthritis Treatment and Mechanisms
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon